The Use of Folic Acid in Chronic Kidney Disease Patients With Anemia

Abstract

Chronic kidney disease (CKD) is defined as decreasing kidney function (GFR < 60 ml/minute/1.73 m2 ) for more than 3 months. Anemia is a common complication of CKD due to a decrease in the hormone erythropoietin related to hemoglobin levels. One of the anemia therapies involves using folic acid. Folic acid helps the process of nucleoprotein synthesis and erythropoiesis maintenance. The objective of this study was to determine the pattern of folic acid applied to CKD patients with anemia at University of Muhammadiyah Malang General Hospital. Observational, descriptive, and retrospective data collection methods were used. The results showed that there were 17 patients (47%) with a single use of folic acid (3x1 mg, oral); the most common pattern of the two-combination was folic acid (3x1 mg, oral) and PRC (250 ml, intravenous [iv]), which was given to 11 patients (65%); and the most common pattern of threecombination was folic acid (3x1 mg, oral), Promavit® (3x1 tab, oral), and PRC (250 ml, iv), which was given to 2 patients or 100%. Of the 16 switch patterns, the most of common combination was a single pattern of folic acid (3x1 mg, oral) and a combination of folic acid (3x1 mg, oral) and PRC (250 ml, iv), given to 7 patients (44%).
 Keywords: folic acid, anemia, chronic kidney disease

Enhancing medication management in hemodialysis patients: Exploring the impact of patient-centered pharmacist care and motivational interviewing

“…A study by Garg et al (2001) conducted among HD patients in Unites States reported that lower level of folic acid has been seen in HD patients due to malnutrition and folate loss through dialysate [29]. Therefore, folic acid intake by HD patients can help to reduce cardiovascular disease by reducing the serum homocysteine levels [30,31]. Besides that, insufficient anemia management with erythropoietin (EPO) was also observed.…”

The role of folic acid supplementation on lowering homocysteine level in chronic kidney disease

“…Cardiovascular abnormality is the most concerning risk factor that leads to CKD. Generally, CKD can be divided into five stages, where End-Stage Renal Disease (ESRD) is a condition where GFR value is less than 15 ml/minute [1]. Initially, in patients with early stage CKD (stage 1-2), patients are mostly asymptomatic without any finding suggesting metabolic disturbances.…”